Targeting Adipose Inflammation in Diabetic Vascular Complications
Monday April 08, 2019
8:00 am
-
10:00 am
Eastern Time (ET)
Room W206 A
CVP
DDD
Chair :
Rhian Touyz
University of Glasgow
Ahmed El-Yazbi
The American University of Beirut
Vasculoprotective pleiotropic effects of anti-diabetic drugs have received a lot of attention since the emergence of recent clinical data describing significant cardiovascular risk reduction in diabetic and/or prediabetic patients treated with certain molecules independent of their hypoglycemic effect. This symposium explores the detrimental role that adipose tissue inflammation plays in the development cardiovascular complications of diabetes. Recent findings regarding signaling pathways underling this deleterious interaction will be presented. Several potential therapeutic targets will be explored, together with novel therapeutic tools currently under clinical investigation. As well, new protective mechanisms for traditional drugs via modulation of adipose inflammation will be highlighted.
Speakers
Michael Czech
- University of Massachusetts Medical School
Adipose Inflammation in Pre-diabetes and Insulin Resistance
Rhian Touyz
- University of Glasgow
Detrimental Signaling from Dysfunctional Adipose Tissue to Vasculature
Allyson Palmer
- Mayo Clinic College of Medicine and Science
Metabolic Disease and Adipose Tissue Senescence: Potential Interventions in Diabetes
Ahmed El-Yazbi
- The American University of Beirut
Adipose Tissue Inflammation and Vascular Dysfunction Preceding Hyperglycemia: Modulation by Anti-Diabetic Drugs
Gavin Oudit
- University of Alberta
Therapeutic Targets in Adipose Tissue in Obesity Related Heart Failure with Preserved Ejection Fraction